SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-19-012843
Filing Date
2019-07-12
Accepted
2019-07-12 07:36:44
Documents
5
Period of Report
2019-08-22
Effectiveness Date
2019-07-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm DEF 14A 229614
2 image00001.jpg GRAPHIC 4338
3 image00003.jpg GRAPHIC 68118
4 image00004.jpg GRAPHIC 111911
5 image00005.jpg GRAPHIC 144024
  Complete submission text file 0001140361-19-012843.txt   683692
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36435 | Film No.: 19952076
SIC: 2836 Biological Products, (No Diagnostic Substances)